Hollencrest Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Hold |
4,305
| – | – | 0.01% | 235 |
|
|
2025
Q1 | $299K | Sell |
4,305
-251
| -6% | -$17.4K | 0.01% | 232 |
|
|
2024
Q4 | $392K | Sell |
4,556
-325
| -7% | -$28K | 0.02% | 217 |
|
|
2024
Q3 | $581K | Sell |
4,881
-996
| -17% | -$119K | 0.02% | 194 |
|
|
2024
Q2 | $839K | Sell |
5,877
-1,132
| -16% | -$162K | 0.04% | 155 |
|
|
2024
Q1 | $900K | Buy |
7,009
+989
| +16% | +$127K | 0.04% | 149 |
|
|
2023
Q4 | $623K | Buy |
6,020
+56
| +0.9% | +$5.79K | 0.06% | 167 |
|
|
2023
Q3 | $542K | Buy |
5,964
+1,130
| +23% | +$103K | 0.06% | 164 |
|
|
2023
Q2 | $391K | Buy |
4,834
+750
| +18% | +$60.7K | 0.04% | 205 |
|
|
2023
Q1 | $325K | Sell |
4,084
-24
| -0.6% | -$1.91K | 0.03% | 219 |
|
|
2022
Q4 | $278K | Buy |
+4,108
| New | +$278K | 0.03% | 219 |
|